PSIL 12.92 AdvisorShares Psychedelics ETF
| Range: | 0.879-17.0 | Vol Avg: | 20096 | Last Div: | 0.11 | Changes: | 0.13 |
| Beta: | 0.97 | Cap: | 0.01B | Currency: | USD | Exchange: | AMEX |
| Sector: | Financial Services | IPO: | Thu Sep 16 2021 | Empoloyees: | |||
| CUSIP: | 00768Y362 | CIK: | 0001408970 | ISIN: | US00768Y3624 | Country: | US |
| CEO: | Website: | https://advisorshares.com | |||||
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The fund is non-diversified.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow